Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years

Eileen J. Kennedy

ORCID-verified (high confidence)As of 12 November 2026

Matched on ORCID iD 0000-0001-5610-1677; OpenAlex author ID A5031991802.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2026: 2 papers

Papers 2

  1. In vitro investigations of troxacitabine (TROX) and 3'-deazaneplanocin (DZNep) combination for pancreatic cancer therapy. Co-author DOI 10.1016/j.bmcl.2026.130600↗
  2. Targeting the WASF3 Regulatory Complex in Pancreatic Cancer Using Stapled Peptides. Last author DOI 10.1021/acs.biochem.6c00200↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Taylor C. Dill · 1 shared paper, 2026
  2. Joseph Manu · 1 shared paper, 2026
  3. May P. Xiong · 1 shared paper, 2026

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.